Next Article in Journal
A Rare Adverse Skin Reaction after 8 Gy of Radiation Therapy to the Thoracic Spine: Case Report and Review of the Literature
Previous Article in Journal
Primary Central Nervous System T-Cell Lymphoma in Aids Patients: Case Report and Literature Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 17
Issue 5
10.3747/co.v17i5.609
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Complete Response of Hepatocellular Carcinoma with Sorafenib and 90y Radioembolization

by
P.K. Chaudhury
1,
M. Hassanain
1,
J.M. Bouteaud
1,
T. Alcindor
2,
C.G. Nudo
1,
D. Valenti
3,
T. Cabrera
3,
P. Kavan
2,
I. Feteih
3 and
P. Metrakos
1,*
1
Department of Surgery, McGill University, and Hepatopancreatobiliary and Transplant Surgery Program, Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada
2
Department of Medical Oncology, McGill University Health Centre, Montreal, QC, Canada
3
Department of Radiology, Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2010, 17(5), 67-69; https://doi.org/10.3747/co.v17i5.609
Submission received: 2 July 2010 / Revised: 7 August 2010 / Accepted: 6 September 2010 / Published: 1 October 2010

Abstract

Advanced hepatocellular carcinoma has a dismal prognosis, with a median overall survival of 7.9 months if untreated and of 10.7 months if treated with sorafenib. We present a case of advanced previously unresectable hepatocellular carcinoma in a 49-year-old man that achieved a pathologic complete response and was made amenable to surgery with sorafenib in combination with 90Y radioembolization. The patient’s survival was more than double the median for patients treated with sorafenib alone.
Keywords: cancer; oncology; surgery; gastrointestinal cancer; oncology; surgery; gastrointestinal

Share and Cite

MDPI and ACS Style

Chaudhury, P.K.; Hassanain, M.; Bouteaud, J.M.; Alcindor, T.; Nudo, C.G.; Valenti, D.; Cabrera, T.; Kavan, P.; Feteih, I.; Metrakos, P. Complete Response of Hepatocellular Carcinoma with Sorafenib and 90y Radioembolization. Curr. Oncol. 2010, 17, 67-69. https://doi.org/10.3747/co.v17i5.609

AMA Style

Chaudhury PK, Hassanain M, Bouteaud JM, Alcindor T, Nudo CG, Valenti D, Cabrera T, Kavan P, Feteih I, Metrakos P. Complete Response of Hepatocellular Carcinoma with Sorafenib and 90y Radioembolization. Current Oncology. 2010; 17(5):67-69. https://doi.org/10.3747/co.v17i5.609

Chicago/Turabian Style

Chaudhury, P.K., M. Hassanain, J.M. Bouteaud, T. Alcindor, C.G. Nudo, D. Valenti, T. Cabrera, P. Kavan, I. Feteih, and P. Metrakos. 2010. "Complete Response of Hepatocellular Carcinoma with Sorafenib and 90y Radioembolization" Current Oncology 17, no. 5: 67-69. https://doi.org/10.3747/co.v17i5.609

APA Style

Chaudhury, P. K., Hassanain, M., Bouteaud, J. M., Alcindor, T., Nudo, C. G., Valenti, D., Cabrera, T., Kavan, P., Feteih, I., & Metrakos, P. (2010). Complete Response of Hepatocellular Carcinoma with Sorafenib and 90y Radioembolization. Current Oncology, 17(5), 67-69. https://doi.org/10.3747/co.v17i5.609

Article Metrics

Back to TopTop